These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34904531)

  • 1. Voriconazole pharmacokinetics in a critically ill patient during extracorporeal membrane oxygenation.
    Lin XB; Hu XG; Xia YZ; Liu XM; Liang T; Chen X; Cai CJ
    J Chemother; 2022 Jul; 34(4):272-276. PubMed ID: 34904531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation.
    Spriet I; Annaert P; Meersseman P; Hermans G; Meersseman W; Verbesselt R; Willems L
    J Antimicrob Chemother; 2009 Apr; 63(4):767-70. PubMed ID: 19218271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of intravenous voriconazole in patients with liver dysfunction: A prospective study in the intensive care unit.
    Lin XB; Huang F; Tong L; Xia YZ; Wu JJ; Li J; Hu XG; Liang T; Liu XM; Zhong GP; Cai CJ; Chen X
    Int J Infect Dis; 2020 Apr; 93():345-352. PubMed ID: 32109625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients.
    Hahn J; Choi JH; Chang MJ
    J Clin Pharm Ther; 2017 Dec; 42(6):661-671. PubMed ID: 28948652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of intravenous sufentanil in critically ill patients supported with extracorporeal membrane oxygenation therapy.
    Hahn J; Yang S; Min KL; Kim D; Jin BH; Park C; Park MS; Wi J; Chang MJ
    Crit Care; 2019 Jul; 23(1):248. PubMed ID: 31288863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of extracorporeal membrane oxygenation on antifungal pharmacokinetics: A systematic review.
    Jendoubi A; Pressiat C; De Roux Q; Hulin A; Ghaleh B; Tissier R; Kohlhauer M; Mongardon N
    Int J Antimicrob Agents; 2024 Feb; 63(2):107078. PubMed ID: 38161046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and target attainment of intravenous posaconazole in critically ill patients during extracorporeal membrane oxygenation.
    Van Daele R; Brüggemann RJ; Dreesen E; Depuydt P; Rijnders B; Cotton F; Fage D; Gijsen M; Van Zwam K; Debaveye Y; Wauters J; Spriet I
    J Antimicrob Chemother; 2021 Apr; 76(5):1234-1241. PubMed ID: 33517360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal Dosing in Critically Ill Patients on Extracorporeal Membrane Oxygenation.
    Lyster H; Shekar K; Watt K; Reed A; Roberts JA; Abdul-Aziz MH
    Clin Pharmacokinet; 2023 Jul; 62(7):931-942. PubMed ID: 37300631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Altered Drug Pharmacokinetics in Critically Ill Adults Receiving Extracorporeal Membrane Oxygenation.
    Ha MA; Sieg AC
    Pharmacotherapy; 2017 Feb; 37(2):221-235. PubMed ID: 27931091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreasing voriconazole requirement in a patient after extracorporeal membrane oxygenation discontinuation: A case report.
    Peterson EL; Chittick PJ; Richardson CL
    Transpl Infect Dis; 2021 Jun; 23(3):e13545. PubMed ID: 33316840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of ciprofloxacin in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study).
    Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Corley A; Diehl A; Levkovich BJ; Pellegrino V; Reynolds C; Rudham S; Wallis SC; Welch SA; Roberts JA; Shekar K; Fraser JF;
    Anaesth Crit Care Pain Med; 2022 Jun; 41(3):101080. PubMed ID: 35472580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetic model-guided optimization of intravenous voriconazole dosing regimens in critically ill patients with liver dysfunction.
    Lin XB; Lui KY; Guo PH; Liu XM; Liang T; Hu XG; Tong L; Wu JJ; Xia YZ; Chen P; Zhong GP; Chen X; Cai CJ
    Pharmacotherapy; 2022 Jan; 42(1):23-33. PubMed ID: 34655497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voriconazole Sequestration During Extracorporeal Membrane Oxygenation for Invasive Lung Aspergillosis: A Case Report.
    Mathieu A; Thiboutot Z; Ferreira V; Benoit P; Grandjean Lapierre S; HÉtu PO; Halwagi A
    ASAIO J; 2022 Mar; 68(3):e56-e58. PubMed ID: 33788798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population Pharmacokinetics and Dosing Optimization of Piperacillin-Tazobactam in Critically Ill Patients on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy.
    Hahn J; Min KL; Kang S; Yang S; Park MS; Wi J; Chang MJ
    Microbiol Spectr; 2021 Dec; 9(3):e0063321. PubMed ID: 34937189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftriaxone Pharmacokinetics and Pharmacodynamics in 2 Pediatric Patients on Extracorporeal Membrane Oxygenation Therapy.
    Cervantes FC; Mizuno T; Dong M; Tang P; Arbough T; Vinks AA; Kaplan JM; Tang Girdwood SC
    Ther Drug Monit; 2023 Dec; 45(6):832-836. PubMed ID: 37725684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population Pharmacokinetics of Levosimendan and its Metabolites in Critically Ill Neonates and Children Supported or Not by Extracorporeal Membrane Oxygenation.
    Bourgoin P; Lecomte J; Oualha M; Berthomieu L; Pereira T; Davril E; Lamoureux F; Joram N; Chenouard A; Duflot T
    Clin Pharmacokinet; 2023 Feb; 62(2):335-348. PubMed ID: 36631687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voriconazole Pharmacokinetics in Critically Ill Patients and Extracorporeal Membrane Oxygenation Support: A Retrospective Comparative Case-Control Study.
    Ronda M; Llop-Talaveron JM; Fuset M; Leiva E; Shaw E; Gumucio-Sanguino VD; Diez Y; Colom H; Rigo-Bonnin R; Puig-Asensio M; Carratalà J; Padullés A
    Antibiotics (Basel); 2023 Jun; 12(7):. PubMed ID: 37508196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of extracorporeal support on antimicrobial pharmacokinetics in critically ill neonatal and paediatric patients: A systematic review.
    Cree ML; Abdul-Aziz MH; Schlapbach LJ; Roberts JA; Parker SL
    Int J Antimicrob Agents; 2024 Oct; 64(4):107311. PubMed ID: 39197687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluctuating Voriconazole Concentrations during Extracorporeal Membrane Oxygenation.
    Vu T; Feih J; Juul J
    J Pharm Pract; 2023 Aug; 36(4):998-1001. PubMed ID: 35612553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The population pharmacokinetics and dose optimization of polymyxin B in critically ill patients with or without extracorporeal membrane oxygenation.
    Ye Q; Wang Q; Chen W; Zhang R; Chen Z; Li P; Zhang X; Zhan Q; Wang C
    J Clin Pharm Ther; 2022 Oct; 47(10):1608-1618. PubMed ID: 35716048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.